Isoray Inc Stock Fundamentals
| ISRDelisted Stock | USD 0.38 0.01 2.70% |
IsoRay Inc fundamentals help investors to digest information that contributes to IsoRay's financial success or failures. It also enables traders to predict the movement of IsoRay Stock. The fundamental analysis module provides a way to measure IsoRay's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to IsoRay stock.
IsoRay |
IsoRay Inc Company Profit Margin Analysis
IsoRay's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current IsoRay Profit Margin | (1.16) % |
Most of IsoRay's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, IsoRay Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, IsoRay Inc has a Profit Margin of -1.1591%. This is 89.66% lower than that of the Biotechnology sector and 78.77% lower than that of the Health Care industry. The profit margin for all United States stocks is 8.73% lower than that of the firm.
IsoRay Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IsoRay's current stock value. Our valuation model uses many indicators to compare IsoRay value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IsoRay competition to find correlations between indicators driving IsoRay's intrinsic value. More Info.IsoRay Inc is currently regarded as number one stock in return on equity category among related companies. It is currently regarded as number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value IsoRay by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for IsoRay's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the IsoRay's earnings, one of the primary drivers of an investment's value.IsoRay Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses IsoRay's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of IsoRay could also be used in its relative valuation, which is a method of valuing IsoRay by comparing valuation metrics of similar companies.IsoRay is currently under evaluation in profit margin category among related companies.
IsoRay Fundamentals
| Return On Equity | -0.17 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | (1.16) % | |||
| Operating Margin | (1.21) % | |||
| Current Valuation | (11.02 M) | |||
| Shares Outstanding | 278.66 M | |||
| Shares Owned By Insiders | 0.76 % | |||
| Shares Owned By Institutions | 6.18 % | |||
| Number Of Shares Shorted | 409.25 K | |||
| Price To Earning | (5.00) X | |||
| Price To Book | 0.74 X | |||
| Price To Sales | 4.14 X | |||
| Revenue | 10.79 M | |||
| Gross Profit | 4.62 M | |||
| EBITDA | (6.86 M) | |||
| Net Income | (7.27 M) | |||
| Cash And Equivalents | 55.89 M | |||
| Cash Per Share | 0.39 X | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 26.18 X | |||
| Book Value Per Share | 0.39 X | |||
| Cash Flow From Operations | (7.71 M) | |||
| Short Ratio | 1.70 X | |||
| Earnings Per Share | (0.04) X | |||
| Target Price | 1.0 | |||
| Number Of Employees | 66 | |||
| Beta | 1.49 | |||
| Market Capitalization | 107 M | |||
| Total Asset | 64.44 M | |||
| Retained Earnings | (82.05 M) | |||
| Working Capital | 12.54 M | |||
| Current Asset | 13.63 M | |||
| Current Liabilities | 1.09 M | |||
| Z Score | -1.4 | |||
| Net Asset | 64.44 M |
About IsoRay Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze IsoRay Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IsoRay using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IsoRay Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Isoray, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. Isoray, Inc. was founded in 1998 and is based in Richland, Washington. Isoray operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 66 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards IsoRay in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, IsoRay's short interest history, or implied volatility extrapolated from IsoRay options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in IsoRay Stock
If you are still planning to invest in IsoRay Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IsoRay's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |